In Ontario, Canada, Kincardine's 7 Acres cannabis greenhouse is ramping up both hiring and construction, with over $70 million expected to be invested to see the entire 340,000-square-foot facility built out by 2019.
Originally envisioned as a six- to 10-year project with about about 100 employees will now staff upwards of 300 employees at full capacity.
7 Acres' parent company, the publicly-traded Supreme Pharmaceuticals, aims to see the facility's production skyrocket from 100kg/month of medical-grade cannabis the test grow room currently produces, to about 1,000kg/week with close to 30 grow rooms at peak.
Supreme Pharmaceutical's chief executive officer John Fowler tol kincardinenews.com that the company has its license to cultivate, which was renewed for a year in March 2017, and is currently awaiting Health Canada approval for a license to sell cannabis, which he said they're confident they'll obtain due to their strong team and proven practices.
“Business-wise, waiting on the license to sell doesn't slow down our expansion,” Fowler said. “The crew is going full-out to complete the project and deliver the 340,000 square-feet as quickly as possible, particularly with the recent news of the legalization for July of 2018.”